Par Drugs And Chemicals Limited - Asset Resilience Ratio
Par Drugs And Chemicals Limited (PAR) has an Asset Resilience Ratio of 3.08% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Par Drugs And Chemicals Limited's Asset Resilience Ratio has changed over time. Check Par Drugs And Chemicals Limited (PAR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Par Drugs And Chemicals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PAR market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs31.31 Million | 3.08% |
| Total Liquid Assets | Rs31.31 Million | 3.08% |
Asset Resilience Insights
- Limited Liquidity: Par Drugs And Chemicals Limited maintains only 3.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Par Drugs And Chemicals Limited Industry Peers by Asset Resilience Ratio
Compare Par Drugs And Chemicals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621 |
Drug Manufacturers - Specialty & Generic | 2.04% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
|
Jw Pharmac
KO:001060 |
Drug Manufacturers - Specialty & Generic | 3.65% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Samjin Pharm
KO:005500 |
Drug Manufacturers - Specialty & Generic | 0.25% |
Annual Asset Resilience Ratio for Par Drugs And Chemicals Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Par Drugs And Chemicals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-03-31 | 0.00% | Rs1.00K ≈ $10.81 |
Rs1.02 Billion ≈ $10.99 Million |
-3.38pp |
| 2023-03-31 | 3.38% | Rs30.02 Million ≈ $324.61K |
Rs888.68 Million ≈ $9.61 Million |
+2.10pp |
| 2022-03-31 | 1.27% | Rs10.02 Million ≈ $108.32K |
Rs786.90 Million ≈ $8.51 Million |
+1.27pp |
| 2019-03-31 | 0.00% | Rs150.00 ≈ $1.62 |
Rs513.55 Million ≈ $5.55 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more